VAXX News and Press, Vaxxinity Inc. From 05/03/22

Spero Therapeutics (SPRO) -52% after announcing new strategic direction focusing on advancing promising clinical-stage pipeline. Chegg (CHGG) -40% on Q1 earnings release. Galmed Pharmaceuticals (GLMD) -19% on Q4 earnings release. Better Therapeutics (BTTX) -16%. Haywa...

Shares of Vaxxinity (NASDAQ:VAXX) dropped ~9% in Monday afternoon trading after the stock skyrocketed on Friday, closing up 84%. The biotech has had several key developments occur over the past few days. Before market open on April 28, Vaxxinity (VAXX) said that results from pa...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Innoviz Technologies (NASDAQ: INVZ ) stock is on the rise Monday after announcing a deal with one of the world’s largest vehicle manufacturers. Source: temp-64GTX/Shutterstock.com Innoviz Technologies h...

Gainers: Silk Road Medical (SILK) +12%. Clene (CLNN) +6%. BioCardia (BCDA) +2%. Veru (VERU) +2%. ERYTECH Pharma (ERYP) +1%. Losers: Global Cord Blood (CO) -28%. Zosano Pharma (ZSAN) -21%. Vaxxinity (VAXX) -17%. HUTCHMED (China) (HCM)...

The U.S. Food and Drug Administration (FDA) granted fast track designation to Vaxxinity's (NASDAQ:VAXX) anti-amyloid beta immunotherapeutic vaccine UB-311 to treat Alzheimer’s disease. "Because our vaccine approach allows for more convenient administration and broad access, UB-311...

DALLAS, May 02, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a company pioneering the development of a new class of immunotherapeutic vaccines, today announced that UB-311, an anti-amyloid beta immunotherapeutic vaccine, has been granted Fast Track designation by the U.S. F...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, Texas-based biotech company Vaxxinity (NASDAQ: VAXX ) closed up an unbelievable 84% higher. Specifically, VAXX stock skyrocketed on news that it has completed an important milestone in its treatment for Parkins...

Gainers: GTY Technology Holdings (GTYH) +114%. Vaxxinity (VAXX) +57%. Zymeworks (ZYME) +35%. Redbox Entertainment (RDBX) +33%. Finch Therapeutics Group (FNCH) +29%. Opiant Pharmaceuticals (OPNT) +29%. Puyi (PUYI) +27%. Cyngn (CYN) +24%. Clearwater (CLW) +24%. Anixa Biosciences (ANIX) +21%. Lo...

The shares of the clinical-stage biotech Vaxxinity (NASDAQ:VAXX) have recorded the biggest intraday gain on Friday since its IPO late last year after the company’s top executives disclosed multiple insider purchases. They include Vaxxinity’s (VAXX) Founder and Chief Executive Of...

Results from UB-312’s Part A first-in-human trials published in Movement Disorders DALLAS, April 28, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced it has co...